Log in
Enquire now
‌

US Patent 9814725 Imidazopyridine compounds and uses thereof

Patent 9814725 was granted and assigned to NeoMed on November, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
NeoMed
NeoMed
Current Assignee
NeoMed
NeoMed
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9814725
Patent Inventor Names
Louis-David Cantin0
Yun-Jin Hu0
Xuehong Luo0
Christophe Buon0
Miroslaw Jerzy Tomaszewski0
Date of Patent
November 14, 2017
Patent Application Number
15423428
Date Filed
February 2, 2017
Patent Primary Examiner
‌
Rebecca Anderson
Patent abstract

This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processesor making such a compound, and intermediates used in such processes.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9814725 Imidazopyridine compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us